1. Home
  2. MLTX vs SITC Comparison

MLTX vs SITC Comparison

Compare MLTX & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • SITC
  • Stock Information
  • Founded
  • MLTX 2021
  • SITC 1965
  • Country
  • MLTX Switzerland
  • SITC United States
  • Employees
  • MLTX N/A
  • SITC N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • SITC Real Estate Investment Trusts
  • Sector
  • MLTX Health Care
  • SITC Real Estate
  • Exchange
  • MLTX Nasdaq
  • SITC Nasdaq
  • Market Cap
  • MLTX 535.3M
  • SITC 461.0M
  • IPO Year
  • MLTX N/A
  • SITC 1993
  • Fundamental
  • Price
  • MLTX $9.40
  • SITC $8.56
  • Analyst Decision
  • MLTX Buy
  • SITC Hold
  • Analyst Count
  • MLTX 9
  • SITC 6
  • Target Price
  • MLTX $37.63
  • SITC $23.30
  • AVG Volume (30 Days)
  • MLTX 9.7M
  • SITC 1.2M
  • Earning Date
  • MLTX 11-06-2025
  • SITC 10-29-2025
  • Dividend Yield
  • MLTX N/A
  • SITC 55.46%
  • EPS Growth
  • MLTX N/A
  • SITC N/A
  • EPS
  • MLTX N/A
  • SITC 6.74
  • Revenue
  • MLTX N/A
  • SITC $173,351,000.00
  • Revenue This Year
  • MLTX N/A
  • SITC N/A
  • Revenue Next Year
  • MLTX N/A
  • SITC N/A
  • P/E Ratio
  • MLTX N/A
  • SITC $1.23
  • Revenue Growth
  • MLTX N/A
  • SITC N/A
  • 52 Week Low
  • MLTX $5.95
  • SITC $8.45
  • 52 Week High
  • MLTX $62.75
  • SITC $17.70
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 23.29
  • SITC 32.53
  • Support Level
  • MLTX $6.56
  • SITC $8.72
  • Resistance Level
  • MLTX $7.48
  • SITC $9.08
  • Average True Range (ATR)
  • MLTX 2.22
  • SITC 0.22
  • MACD
  • MLTX -4.37
  • SITC 0.07
  • Stochastic Oscillator
  • MLTX 6.07
  • SITC 17.32

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About SITC SITE Centers Corp.

SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.

Share on Social Networks: